Overview
Status
Active
Registry date
2023-04-07
Share capital
5,000.00 PLN
Registered address
os. Zygmunta Starego 13/31, 60-684 Poznań, Poland
Electronic delivery address
AE:PL-31328-66040-JSJSI-33
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 18 days early.
- 202524/06/2026
- 202401/07/2025
- 202327/06/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 45.70kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -16.30kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 56.95kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 45.00kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Maciej Jan Dąbrowski – President of the Management Board
Katarzyna Romana Zawadzka – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Małgorzata Beata Dąbrowskaage 38 | 10 | $135.06 | 10% |
Maciej Jan Dąbrowskiage 38 | 90 | $1,215.56 | 90% |
Maciej Jan Dąbrowski and Małgorzata Beata Dąbrowska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-04-25.
28 1020 4027 0000 1502 1839 3112- 61 1020 4027 0000 1302 1839 3101
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 7, 2026 | Aid for research and development projects: industrial research | $408.1K$408,130 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| May 7, 2026 | Aid for research and development projects: experimental development | $50,513$50,513 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
Last updated: 2026-06-24